India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: ReportCovaxin and Covishield

India will procure around 27-28 crore COVID-19 vaccine doses of Serum Institute of India's Covishield and Bharat Biotech's Covaxin in the month of October.

However, the Covid-19 vaccine doses that are to be procured will not include the shots from Zydus Cadila and Biological E, government sources were quoted by ANI as saying.

It should be noted that over 25 crore COVID-19 doses were procured for India's vaccination drive in September.

The development comes as the Central government plans to administer over 100 crore COVID-19 vaccine doses before mid-October.

According to the report, the Centre is expected to achieve the target of 100 crore doses administration between 10 October and 12 October.

So far, India has administered over 88.97 crore vaccine doses under its nationwide vaccination drive.

India has so far approved six Covid-19 vaccines for use in its vaccination drive. These vaccines include Serum Institute of India's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russian Sputnik V Covid vaccine, Moderna's mRNA vaccine and J&J's Covid vaccine.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement